New preclinical research in Neuropsychopharmacology focuses on the unique mechanism and site of action of evenamide as a ...

A transformative moment in the global fight against obesity has emerged with the announcement of positive topline results ...

D-150 Phase 3 program in wet AMD advancing ahead of plan, with expected 4FRONT-1 data readout accelerated to H1 2027 from H2 2027 and 4FRONT-2 initiated ahead of schedulePresented positive 60-week ...

When markets are shaky, who do you trust with your money? A recent study provides useful insights into the value that ...

Dealers, especially those focused on primary market work, may be running more often than not on razor-thin or nonexistent ...

Discover how Purdue University is embracing artificial intelligence (AI) in education and the impact it will have on college students' learning experiences.

In a landmark move towards inclusive higher education, Hyderabad Sind National Collegiate University (HSNC University), ...

Detailed price information for Kymera Therapeutics Inc (KYMR-Q) from The Globe and Mail including charting and trades.

Cash, cash equivalents, marketable securities and restricted cash as of June 30, 2025, totaled approximately $408.2 million VYGLXIA NDA for spinocerebellar ataxia ...

D-150 Phase 3 program in wet AMD advancing ahead of plan, with expected 4FRONT-1 data readout accelerated to H1 2027 from H2 2027 and 4FRONT-2 initiated ahead of schedulePresented positive 60-week res ...

Study resultsNewron notes the publication of new preclinical research suggesting evenamide ameliorates schizophrenia-related dysfunction 11.08.2025 / 07:00 CET/CESTThe issuer is solely responsible for ...

Too often, the participation of refugees in shaping government policy is framed as something refugees demand. But it should ...